PortfoliosLab logoPortfoliosLab logo
CLPS vs. IRWD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLPS vs. IRWD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CLPS Incorporation (CLPS) and Ironwood Pharmaceuticals, Inc. (IRWD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLPS achieves a 6.98% return, which is significantly lower than IRWD's 25.52% return.


CLPS

1D
4.79%
1M
4.60%
6M
-18.16%
YTD
6.98%
1Y
-7.80%
3Y*
-0.12%
5Y*
-22.13%
10Y*
ALL TIME*
-18.66%

IRWD

1D
13.40%
1M
-2.31%
6M
-13.50%
YTD
25.52%
1Y
448.35%
3Y*
-27.82%
5Y*
-20.44%
10Y*
-11.17%
ALL TIME*
-6.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$13.05K$45.30K$35.97K
$6.27M$9.14M$9.75M

CLPS vs. IRWD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
CLPS
CLPS Incorporation
6.98%-31.34%22.65%0.73%-40.26%-35.53%-39.20%106.61%-57.99%
IRWD
Ironwood Pharmaceuticals, Inc.
25.52%-23.93%-61.28%-7.67%6.26%2.37%-14.43%28.47%-40.46%

Correlation

The correlation between CLPS and IRWD is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.04

Correlation (3Y)
Balances recent behavior with more history.

0.02

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.04

Correlation (All Time)
Calculated using the full available price history since May 24, 2018

0.06

Fundamentals

Market Cap

CLPS:

$25.64M

IRWD:

$696.31M

EPS

CLPS:

-$0.26

IRWD:

$0.87

PS Ratio

CLPS:

0.08

IRWD:

2.04

Total Revenue (TTM)

CLPS:

$320.60M

IRWD:

$361.51M

Gross Profit (TTM)

CLPS:

$73.05M

IRWD:

$254.55M

EBITDA (TTM)

CLPS:

-$4.37M

IRWD:

$204.95M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CLPS Incorporation

Ironwood Pharmaceuticals, Inc.

Return for Risk

CLPS vs. IRWD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CLPS
CLPS Risk / Return Rank: 4444
Overall Rank
CLPS Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
CLPS Sortino Ratio Rank: 4747
Sortino Ratio Rank
CLPS Omega Ratio Rank: 4848
Omega Ratio Rank
CLPS Calmar Ratio Rank: 4141
Calmar Ratio Rank
CLPS Martin Ratio Rank: 4242
Martin Ratio Rank

IRWD
IRWD Risk / Return Rank: 9898
Overall Rank
IRWD Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
IRWD Sortino Ratio Rank: 9797
Sortino Ratio Rank
IRWD Omega Ratio Rank: 9696
Omega Ratio Rank
IRWD Calmar Ratio Rank: 9999
Calmar Ratio Rank
IRWD Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CLPS vs. IRWD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CLPS Incorporation (CLPS) and Ironwood Pharmaceuticals, Inc. (IRWD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLPSIRWDDifference
Sharpe ratioReturn per unit of total volatility

-4.66

Sortino ratioReturn per unit of downside risk

-3.68

Omega ratioGain probability vs. loss probability

1.08

1.50

-0.42

Calmar ratioReturn relative to maximum drawdown

-0.10

10.49

-10.59

Martin ratioReturn relative to average drawdown

-0.13

21.29

-21.42

CLPS vs. IRWD - Sharpe Ratio Comparison

The current CLPS Sharpe Ratio is -0.06, which is lower than the IRWD Sharpe Ratio of 4.60. The chart below compares the historical Sharpe Ratios of CLPS and IRWD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLPS vs. IRWD - Drawdown Comparison

The maximum CLPS drawdown since its inception was -95.00%, roughly equal to the maximum IRWD drawdown of -97.31%. Use the drawdown chart below to compare losses from any high point for CLPS and IRWD.


Loading charts...

Drawdown Indicators


CLPSIRWDDifference

Max Drawdown

Largest peak-to-trough decline

-95.00%

-97.31%

+2.31%

Max Drawdown (1Y)

Largest decline over 1 year

-50.42%

-43.60%

-6.82%

Max Drawdown (3Y)

Largest decline over 3 years

-50.42%

-96.33%

+45.91%

Max Drawdown (5Y)

Largest decline over 5 years

-77.97%

-96.33%

+18.36%

Max Drawdown (10Y)

Largest decline over 10 years

-97.31%

Current Drawdown

Current decline from peak

-93.68%

-79.92%

-13.76%

Average Drawdown

Average peak-to-trough decline

-81.40%

-39.66%

-41.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.68%

21.45%

+16.23%

Volatility

CLPS vs. IRWD - Volatility Comparison

CLPS Incorporation (CLPS) has a higher volatility of 23.64% compared to Ironwood Pharmaceuticals, Inc. (IRWD) at 21.63%. This indicates that CLPS's price experiences larger fluctuations and is considered to be riskier than IRWD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLPSIRWDDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.64%

21.63%

+2.01%

Volatility (6M)

Calculated over the trailing 6-month period

42.83%

55.73%

-12.90%

Volatility (1Y)

Calculated over the trailing 1-year period

81.72%

99.94%

-18.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.84%

73.90%

-9.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

103.35%

61.35%

+42.00%

Dividends

CLPS vs. IRWD - Dividend Comparison

Neither CLPS nor IRWD has paid dividends to shareholders.


PositionTTM2025202420232022
CLPS
CLPS Incorporation
0.00%0.00%11.11%9.62%4.46%
IRWD
Ironwood Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%

Financials

CLPS vs. IRWD - Financials Comparison

This section allows you to compare key financial metrics between CLPS Incorporation and Ironwood Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

CLPS vs. IRWD - Profitability Comparison

The chart below illustrates the profitability comparison between CLPS Incorporation and Ironwood Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

CLPS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, CLPS Incorporation reported a gross profit of 19.55M and revenue of 85.09M. Therefore, the gross margin over that period was 23.0%.

IRWD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Ironwood Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 106.51M. Therefore, the gross margin over that period was 0.0%.

CLPS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, CLPS Incorporation reported an operating income of 475.80K and revenue of 85.09M, resulting in an operating margin of 0.6%.

IRWD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Ironwood Pharmaceuticals, Inc. reported an operating income of 72.57M and revenue of 106.51M, resulting in an operating margin of 68.1%.

CLPS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, CLPS Incorporation reported a net income of 83.02K and revenue of 85.09M, resulting in a net margin of 0.1%.

IRWD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Ironwood Pharmaceuticals, Inc. reported a net income of 89.57M and revenue of 106.51M, resulting in a net margin of 84.1%.


Frequently Asked Questions


CLPS and IRWD have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLPS has higher volatility (23.64%) compared to IRWD (21.63%). In terms of maximum drawdown, CLPS dropped -95.00% vs IRWD's -97.31%.

IRWD currently has the higher Sharpe Ratio (4.60 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLPS and IRWD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer